300254SZSE

Compensation and Assessment Committee's Review on the List of Reserved Grant Recipients for the 2025 Restricted Stock Incentive Plan

Qianyuan Pharmaceutical Co., Ltd.··2p

Full Translation

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Compensation and Assessment Committee's Review on the List of Reserved Grant Recipients for the 2025 Restricted Stock Incentive Plan — Qianyuan Pharmaceutical Co., Ltd. | SZSE Releases